methamphetamine has been researched along with hydrogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Fujita, Y; Hirayama, M; Ichihara, M; Ito, M; Kajita, Y; Maesawa, S; Masuda, A; Ohno, K; Ohsawa, I; Ohta, S; Suzuki, Y | 1 |
| Cong, B; Hui, R; Liu, Y; Luo, Y; Ma, C; Shen, X; Wang, J; Wen, D; Xie, B; Yu, F | 1 |
2 other study(ies) available for methamphetamine and hydrogen
| Article | Year |
|---|---|
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
Topics: Administration, Oral; Adrenergic Agents; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Hydrogen; Immunohistochemistry; Injections, Intraperitoneal; Male; Methamphetamine; Microinjections; Nerve Degeneration; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2009 |
Molecular hydrogen attenuates methamphetamine-induced behavioral sensitization and activation of ERK-ΔFosB signaling in the mouse nucleus accumbens.
Topics: Animals; Central Nervous System Sensitization; Dose-Response Relationship, Drug; Hydrogen; Locomotion; Male; Malondialdehyde; MAP Kinase Signaling System; Methamphetamine; Mice; Nucleus Accumbens; Phosphorylation; Proto-Oncogene Proteins c-fos; Reactive Oxygen Species | 2020 |